Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Wellcome Trust has awarded a two-year extension to the grant for our Wellcome Centre for Integrative Neuroimaging. This means that WIN is funded through to April 2024.

Group of researchers from Wellcome Centre for Integrative Neuroimaging

The Wellcome Centre for Integrative Neuroimaging (WIN) was established in 2017. It bridges the gap between laboratory neuroscience and human health, by performing multi-scale studies spanning from animal models through to human populations.

The extension is testament to the progress that WIN has demonstrated so far against its vision in all five of its themes: cross-species relationships; cross-scale integration; population data-mining; clinical neuroimaging and open neuroimaging.

WIN researchers have so far generated 698 peer-reviewed publications (and 152 preprints). These papers have collectively gathered 4807 citations to date.

The work of WIN staff has had an impact in many areas, including:

  • Clinical discovery (e.g. throuh the licensing of its software library (FSL) to non-academic users in clinical settings)
  • Clinical practice (e.g. establishing the ‘Brain Health Centre’, opening to memory clinic patients in spring 2020)
  • Engaging industry (e.g. hosting five industry-funded PhD students)
  • Scientific practice: (e.g. influencing neuroimaging research practice via FSL. The main FSL paper has been cited >9000 times).
  • Public debate (e.g. holding a day for patients and public on ‘Building better brain research’).

WIN has also had an impact more locally, initiating new collaborations and leveraging further funding. Fifty-three PhD students have completed since WIN began, and facilities have been enhanced (including the installation of a new rodent scanner and a new MEG scanner).

WIN has ensured that working practices reflect its values, including openness and inclusivity. For example, they have established working groups in Open Science and Equality, Diversity and Inclusion.

Core staff have been recruited, including Jason Lerch (heading up the small-animal imaging facility), Ben Seymour (Wellcome Clinical Research Fellow) and Madalena Fonseca (preclinical functional MRI).

The extension will allow WIN to establish incentives (e.g seed grants) and support (e.g facilitators) for projects that take mechanism to clinical population, or basic neuroscience to clinical translation. It will also provide resources to develop their cutting-edge work on building a positive research culture.

Similar stories

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

How our dreams changed during the COVID-19 pandemic

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.